Direxion Daily S&P Biotech Bull 3X Shares
NYSE Arca:LABU

  • LAST PRICE
    115.80
  • TODAY'S CHANGE (%)
    0.00 (0.00%)
  • Bid / Lots
    115.82/ 1
  • Ask / Lots
    116.75/ 2
  • Open / Previous Close
    112.43 / 115.80
  • Day Range
    110.88
    116.47
  • 52 Week Range
    48.40
    176.99
  • Volume
    1,464,855
  • Overall Morningstar Rating
    Not Ratedout of funds

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Daily Premium/Discount

Bar Graph.See accessible table below
ETFs trading at a price higher than its Net Asset Value (NAV) is said to be trading at a premium, while those trading at price lower than its NAV is said to be at a discount. By showing the daily premium/discount percentage, we can see the trend in market sentiments, regarding the value of an ETF over time.

Holdings Diversification

Asset Class
US Stock		62.1%
Cash		25.1%
Other		10.9%
Non-US Stock		1.9%
Convertible		0
Non-US Bond		0
Sectors
Healthcare64.0%
Basic Mat.0
Communication Services0
Consumer Cyclical0
Consumer Defensive0
Energy0
Financial Serv.s0
Industrials0
Real Estate0
Technology0
Utilities0
Geographic Region
United States		97.3%
Europe		0.8%
Latin America		0
Africa		0
Canada		0
Asia/Oceania		0
As of 2024-04-30

Top 10 Holdings

Company NamePositionAllocation
Allocation
1 Month Change
Market Value
Goldman Sachs Sterling FixInc Port Inc
Long
10.9%
-9.35%
$106.9M
S&P Biotechnology Select Industry Index Swap
Long
5.2%
-15.67%
$50.7M
S&P Biotechnology Select Industry Index Swap
Short
5.2%
+38.96%
$-50.7M
ALPN
Alpine Immune Sciences Inc
Long
1.2%
+0.71%
$11.8M
Goldman Sachs Fin Gov 465 Institut
Long
0.9%
-34.31%
$8.5M
RVMD
Revolution Medicines Inc Ordinary Shares
Long
0.8%
+0.71%
$8.3M
IBRX
ImmunityBio Inc Ordinary Shares
Long
0.8%
+0.71%
$8.2M
VKTX
Viking Therapeutics Inc
Long
0.8%
+0.71%
$7.9M
MRNA
Moderna Inc
Long
0.8%
+0.71%
$7.7M
EXEL
Exelixis Inc
Long
0.8%
+0.71%
$7.6M
As of 2024-05-15

Reports

No reports available

Morningstar Ratings

Time HorizonStar Rating
Overall RatingNot Rated
3 Year RatingNot Rated
5 Year RatingNot Rated
10 Year RatingNot Rated
As of 2024-04-30

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

ETF Profile
Best Fit Index
---
Category
Trading--Leveraged Equity
Sponsor
Rafferty Asset Management, LLC
Inception
May 28, 2015
As of 2024-04-30

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Holding Details
Total Net Assets$949.1M
Shares Out.10.0M
Net Asset Value (NAV)$111.64
Prem/Discount to NAV0.13%
P/E Ratio---
Dividend Yield0.50%
Dividend per Share0.58 USD
Ex-Dividend Date03/19/2024
Dividend Payment Date03/26/2024
Beta---
Morningstar Investment StyleTrading--Leveraged Equity
Equity Style
Small Cap Growth
Credit Quality / Duration
---
Fees & Expenses
Actual Management Fee0.75%
Actual Mgmt. Expense Ratio (MER)1.26%